Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does postoperative radiochemotherapy improve survival in patients with rectal cancer?

Nature Clinical Practice Oncology volume 4, pages 82–83 (2007)Cite this article

boxed-textSmalley SR et al. (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24: 3542–3547

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. O'Connell MJ et al. (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502–507

    Article  CAS  Google Scholar 

  2. Tepper JE et al. (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control—final report of Intergroup 0114. J Clin Oncol 20: 1744–1750

    Article  CAS  Google Scholar 

  3. Sauer R et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731–1740

    Article  CAS  Google Scholar 

  4. Kapiteijn E et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638–646

    Article  CAS  Google Scholar 

  5. Tepper JE et al. (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19: 157–163

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Radiation Oncology, University of North Carolina School of Medicine, Campus Box No. 7512, NC Clinical Cancer Center, Rm 1043, 101 Manning Drive, Chapel Hill, NC 27599–7512, USA tepper@med.unc.edu

Authors and Affiliations

  1. JE Tepper is Professor and Chair of the Department of Radiation Oncology at the University of North Carolina School of Medicine and a member of the UNC/Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.,

    Joel E Tepper

Authors
  1. Joel E Tepper
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

JE Tepper declared he has served on advisory boards for Sanofi-Aventis and Bristol Myers Squibb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tepper, J. Does postoperative radiochemotherapy improve survival in patients with rectal cancer?. Nat Rev Clin Oncol 4, 82–83 (2007). https://doi.org/10.1038/ncponc0696

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0696

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing